K Toda, K Kawada, M Iwamoto, S Inamoto, T Sasazuki… - Neoplasia, 2016 - Elsevier
A number of clinical trials have shown that KRAS mutations of colorectal cancer (CRC) can
predict a lack of responses to anti-epidermal growth factor receptor–based therapy …